Qitai Zhao

5PUBLICATIONS
54CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 11, 2026
H2AFY2 suppresses exhaustion and enhances antitumor activity of CAR-T cells through transcriptional and epigenetic modifications.

|May 01, 2026
Citraconate preserves T cell stemness and antitumor immunity.

|Oct 20, 2025
TREM2-Mediated Cholesterol Efflux in Macrophages Inhibits Anti-Tumor Immunity via Limitation of CD4+ T and NK Cells.

Yunhan Wang, Weina Yu, Xinxin Wang

|Jun 28, 2025
HMGB1 inhibits the IFN-γ-induced PD-L1 expression in NSCLC.

Shumin Wang, Feng Li, Liubo Zhang

|Sep 16, 2024
Peripheral Blood-Derived PD-1/CD28-CD19 CAR-Modified PD-1+ T-Cell Therapy in Patients with Solid Tumors.

Zhen Zhang, Xuan Zhao, Qitai Zhao

Pageof 1

Frequent Collaborators

5 joint publications

Yi Zhang

2 joint publications

Zhen Zhang

2 joint publications

Xuan Zhao

2 joint publications

Xinfeng Chen